Polymorphisms in ER-α gene interact with estrogen receptor status in breast cancer survival

Clinical Cancer Research

Volumn 11, Issue 3, 2005, Pages 1093-1098

  Boyapati, Sonia M ^a   Xiao, Ou Shu ^a,c   Zhi, Xian Ruan ^b   Cail, Qiuyin ^a   Smith, Jeffrey R ^a   Wen, Wanqing ^a   Gao, Yu Tang ^a   Zheng, Wei ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SHANGHAI CANCER INSTITUTE   (China)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE INTERACTION; GENETIC POLYMORPHISM; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; GT GENE; HUMAN; PRIORITY JOURNAL; PVUII GENE; RECEPTOR GENE; XBAI GENE;

ADULT; ALLELES; BREAST NEOPLASMS; COHORT STUDIES; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DINUCLEOTIDE REPEATS; DNA, NEOPLASM; ESTROGEN RECEPTOR ALPHA; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 12944316447     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Hall J, Couse J, Korach K. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 2001;276:36869-72.
2. Jensen EV, Jordan VC. The estrogen receptor: a model for molecular medicine. Clinical Cancer Res 2003;9:1980-9.
3. Yaich L, Dupont WD, Cacener DR, Pari FF. Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. Cancer Res 1992;52:77-83.
4. Pari FF, Cavener DR, Dupont WD. Genomic DNA analysis of the estrogen receptor gene in breast cancer. Breast Cancer Res Treat 1989;14:57-64.
5. Anderson TI, Heimdal KR, Skrede M, Tveit K, Berg K, Borreson A-L. Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Hum Genet 1994;94:665-70.
6. Shin A, Kim D, Nishio H, et al. Estrogen receptor α polymorphism and breast cancer risk. Breast Cancer Res Treat 2003;80:127-31.
7. Cai Q, Shu XO, Jin F, et al. Genetic polymorphisms in the estrogen receptor α gene and risk of breast cancer: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 2003;12:853-9.
8. Cai Q, Gao YT, Wen W, et al. Association of breast cancer risk with a GT dinucleotide repeat polymorphism upstream of the estrogen receptor-α gene. Cancer Res 2003;63:5727-30.
9. Sand P, Luckhaus C, Schlurmann K, Gotz M, Deckert J. Untangling the human estrogen receptor gene structure. J Neural Transm 2002;109:567-83.
10. Hayashi SI, Eguchi H, Tanimoto K, et al. The expression and function of estrogen receptor α and β in human breast cancer and its clinical application. Endocr Relat Cancer 2003;10:193-202.
11. Murphy L, Cherlet T, Lewis A, Banu Y, Watson P. New insights into estrogen receptor function in human breast cancer. Ann Med 2003;35:614-31.
12. Kang H-J, Kim S-W, Kim HJ, et al. Polymorphisms in the estrogen receptor-α gene and breast cancer risk. Cancer Lett 2002;178:175-80.
13. Shearman AM, Cupples LA, Demissie S, et al. Association between estrogen receptor α gene variation and cardiovascular disease. JAMA 2003;290:2263-70.
14. Herrington DM, Howard TD, Hawkins GA, et al. Estrogen receptor polymorphisms and effects of estrogen replacement on high density lipoprotein cholesterol in women with coronary disease. N Engl J Med 2002;346:967-74.
15. Kobayashi N, Fujino T, Shirogane T, et al. Estrogen receptor α polymorphism as a genetic marker for bone loss, vertebral fractures, and susceptibility to estrogen. Maturitas 2002;41:193-201.